TRI LOCUM PARTNERS LP Neurocrine Biosciences, Inc. Transaction History

TRI LOCUM PARTNERS LP portfolio value:

$20.85M
portfolio value

Neurocrine Biosciences, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase 0.00% 196.39K shares 20.85M $106.21 196.39K
Q1 2021 share Decrease -100.00% -7.17K shares -688K $97.25 0
Q4 2020 share Increase 0.00% 7.17K shares 688K $95.85 7.17K